AUTEK(300595.SZ)

Company Encyclopedia

AUTEK

300595.SZ

Autek China Inc. engages in the research and development, production, and sale of optometry products and related supporting products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It also provides ophthalmic and optometry medical devices.

335.42 B

300595.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update

Health Care SuppliesIndustry

Industry Ranking17/40

Industry medianC

Industry averageC

Score Analysis

Peer Comparison

Criteria
Rating
Profit ScoreB
- ROE9.39%B
- Profit Margin25.26%A
- Gross Margin71.61%A
Growth ScoreC
- Revenue YoY0.83%C
- Net Profit YoY-13.74%D
- Total Assets YoY1.99%C
- Net Assets YoY3.44%C
Cash ScoreC
- Cash Flow Margin146.37%B
- OCF YoY0.83%C
Operating ScoreD
- Turnover0.29D
Debt ScoreA
- Gearing Ratio13.63%A

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
陶悦群	33.38%	No Change	23/04/2026
南京欧陶信息科技有限公司	11.22%	No Change	23/04/2026
合肥欧普民生投资管理合伙企业(有限合伙)	3.1%	No Change	23/04/2026
中国银行股份有限公司-华宝中证医疗交易型开放式指数证券投资基金	2.08%	2.13 M	23/04/2026
香港中央结算有限公司	0.53%	-5.29 M	23/04/2026
招商银行股份有限公司-永赢中证全指医疗器械交易型开放式指数证券投资基金	0.47%	1.49 M	23/04/2026
严罡	0.25%	No Change	23/04/2026
朱水胜	0.22%	No Change	23/04/2026
陶文涛	0.2%	No Change	23/04/2026
中信证券股份有限公司	0.2%	-667.29 K	23/04/2026

News

AUTEK(300595.SZ)

Financial Score

Valuation analysis

Institutional View & Shareholder

Analyst Ratings

AUTEK: Obtained the "Drug Manufacturing License"

AUTEK released its performance for the first three quarters, with a net profit attributable to the parent company of 442 million yuan, a decrease of 15.41%

AUTEK: Soft hydrophilic contact lenses have obtained medical device registration certificates

AUTEK has obtained a medical device registration certificate

AUTEK: The company holds a cautious attitude towards the newly established optometry terminals